178 related articles for article (PubMed ID: 12773327)
1. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Marcos E; Adnot S; Pham MH; Nosjean A; Raffestin B; Hamon M; Eddahibi S
Am J Respir Crit Care Med; 2003 Aug; 168(4):487-93. PubMed ID: 12773327
[TBL] [Abstract][Full Text] [Related]
2. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension.
Marcos E; Fadel E; Sanchez O; Humbert M; Dartevelle P; Simonneau G; Hamon M; Adnot S; Eddahibi S
Circ Res; 2004 May; 94(9):1263-70. PubMed ID: 15059929
[TBL] [Abstract][Full Text] [Related]
4. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.
Eddahibi S; Hanoun N; Lanfumey L; Lesch KP; Raffestin B; Hamon M; Adnot S
J Clin Invest; 2000 Jun; 105(11):1555-62. PubMed ID: 10841514
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR
J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538
[TBL] [Abstract][Full Text] [Related]
6. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.
MacLean MR; Deuchar GA; Hicks MN; Morecroft I; Shen S; Sheward J; Colston J; Loughlin L; Nilsen M; Dempsie Y; Harmar A
Circulation; 2004 May; 109(17):2150-5. PubMed ID: 15078799
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.
Keegan A; Morecroft I; Smillie D; Hicks MN; MacLean MR
Circ Res; 2001 Dec; 89(12):1231-9. PubMed ID: 11739290
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
10. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
Guignabert C; Raffestin B; Benferhat R; Raoul W; Zadigue P; Rideau D; Hamon M; Adnot S; Eddahibi S
Circulation; 2005 May; 111(21):2812-9. PubMed ID: 15927991
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice.
Abid S; Houssaini A; Chevarin C; Marcos E; Tissot CM; Gary-Bobo G; Wan F; Mouraret N; Amsellem V; Dubois-Randé JL; Hamon M; Adnot S
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(6):L500-8. PubMed ID: 22797248
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.
Delaney C; Sherlock L; Fisher S; Maltzahn J; Wright C; Nozik-Grayck E
Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L871-L881. PubMed ID: 29345193
[TBL] [Abstract][Full Text] [Related]
13. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?
Eddahibi S; Raffestin B; Hamon M; Adnot S
J Lab Clin Med; 2002 Apr; 139(4):194-201. PubMed ID: 12024106
[TBL] [Abstract][Full Text] [Related]
14. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension.
Morecroft I; Pang L; Baranowska M; Nilsen M; Loughlin L; Dempsie Y; Millet C; MacLean MR
Cardiovasc Res; 2010 Feb; 85(3):593-603. PubMed ID: 19736308
[TBL] [Abstract][Full Text] [Related]
16. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.
Ase AR; Reader TA; Hen R; Riad M; Descarries L
J Neurochem; 2001 Aug; 78(3):619-30. PubMed ID: 11483665
[TBL] [Abstract][Full Text] [Related]
17. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Ni W; Wilhelm CS; Bader M; Murphy DL; Lookingland K; Watts SW
J Pharmacol Exp Ther; 2005 Sep; 314(3):953-60. PubMed ID: 15901794
[TBL] [Abstract][Full Text] [Related]
18. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats.
Eddahibi S; Adnot S; Frisdal E; Levame M; Hamon M; Raffestin B
J Pharmacol Exp Ther; 2001 Apr; 297(1):148-54. PubMed ID: 11259539
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
